Key facts
- It has raised $250K; the latest was Later Stage VC in Jan 2025.
- Notable investors include Draper Associates, Massachusetts Institute of Technology, 2b AHEAD Ventures, Salk Institute.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for NeuroVigil
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroVigil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroVigil
Operator of a neurotechnology development company intended to monitor and generate readings and automated readings of brain wave data. The company utilizes non-invasive wireless brain recording technology and advanced computational algorithms to develop proprietary brain monitors and sophisticated machine learning algorithms that detect a constellation of biomarkers of pathologies in asymptomatic individuals, enabling pharmaceutical companies to utilize EEG recordings to analyze drug efficacy and screen for biomarker data indicating neuropathologies.
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2007
- Website
- neurovigil.com/
- Ownership
- Privately Held (backing)
NeuroVigil doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroVigil shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroVigil in its N-PORT filings yet. We sweep new filings monthly.